Compare Krispy Kreme Inc (DNUT) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Krispy Kreme Inc vs GSK plc — how do they compare? Krispy Kreme Inc trades at $3.13 (market cap $537.85M), while GSK plc trades at $50.5 (market cap $102.60B). The key difference: GSK plc is far larger — about 190.8× Krispy Kreme Inc's market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| DNUT | GSK | |
|---|---|---|
Market Cap | $537.85M | $102.60B |
Sector | Consumer Staples | Health |
52-Week High | $4.70 | $61.18 |
52-Week Low | $2.92 | $38.22 |
Enterprise Value | $1.78B | $123.04B |
Dividend Yield | 3.47% | 3.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Krispy Kreme Inc
Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates in 30 countries through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S. and Canada, includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line
Read more on DNUT →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
